study group,sample,group,patient,Age,Gender,SLEDAI,Treatment,Treatment Response,Timepoint
HD,HD10,Healthy_control,P4,40,female,-,-,-,-
HD,HD11,Healthy_control,P5,43,female,-,-,-,-
HD,HD14,Healthy_control,P6,27,male,-,-,-,-
HD,HD15,Healthy_control,P7,33,female,-,-,-,-
HD,HD16,Healthy_control,P8,25,female,-,-,-,-
HD,HD17,Healthy_control,P9,40,female,-,-,-,-
HD,HD18,Healthy_control,P10,33,female,-,-,-,-
HD,HD19,Healthy_control,P11,38,female,-,-,-,-
HD,HD20,Healthy_control,P12,33,female,-,-,-,-
HD,HD21,Healthy_control,P13,24,female,-,-,-,-
HD,HD22,Healthy_control,P14,26,female,-,-,-,-
HD,HD23,Healthy_control,P15,23,female,-,-,-,-
HD,HD24,Healthy_control,P16,23,female,-,-,-,-
HD,HD25,Healthy_control,P17,30,female,-,-,-,-
HD,HD26,Healthy_control,P18,46,female,-,-,-,-
HD,HD27,Healthy_control,P19,37,female,-,-,-,-
HD,HD28,Healthy_control,P20,49,male,-,-,-,-
HD,HD29,Healthy_control,P21,50,female,-,-,-,-
HD,HD30,Healthy_control,P22,38,male,-,-,-,-
HD,HD31,Healthy_control,P23,49,female,-,-,-,-
SLE-drug,S002,MDA,P24,36,Female,8,belimumab,Responder,baseline
SLE-drug,S014,MDA,P25,42,Female,8,belimumab,Responder,baseline
SLE-drug,S093,MDA,P26,26,Female,6,belimumab,Non-Responder,baseline
SLE-drug,S103,HDA,P27,41,female,14,Telitacicept,Responder,baseline
SLE-drug,S114,MDA,P28,21,female,6,belimumab,Responder,baseline
SLE-drug,S126,HDA,P29,40,female,21,belimumab,Non-Responder,baseline
SLE-drug,S179,HDA,P30,20,Female,14,Telitacicept,Non-Responder,baseline
SLE-drug,S192,Inactive,P24,36,Female,0,belimumab,Responder,6M
SLE-drug,S253,HDA,P30,20,Female,9,Telitacicept,Non-Responder,1M
SLE-drug,S271,HDA,P31,24,female,12,belimumab,Non-Responder,baseline
SLE-drug,S298,MDA,P26,26,Female,8,belimumab,Non-Responder,5M
SLE-drug,S321,MDA,P27,41,female,7,Telitacicept,Responder,6M
SLE-drug,S330,LDA,P25,42,Female,4,belimumab,Responder,6M
SLE-drug,S386,LDA,P28,21,female,2,belimumab,Responder,6M
SLE-drug,S401,HDA,P29,40,female,12,belimumab,Non-Responder,6M
SLE-drug,S478,MDA,P32,32,female,8,Telitacicept,Non-Responder,baseline
SLE-drug,S484,HDA,P33,35,female,14,belimumab,Non-Responder,baseline
SLE-drug,S495,MDA,P34,41,female,8,belimumab,Responder,baseline
SLE-drug,S497,HDA,P35,55,female,11,belimumab,Responder,baseline
SLE-drug,S631,HDA,P31,24,female,12,belimumab,Non-Responder,6M
SLE-drug,S692,HDA,P33,35,female,13,belimumab,Non-Responder,6M
SLE-drug,S693,LDA,P34,41,female,4,belimumab,Responder,6M
SLE-drug,S753,MDA,P32,32,female,8,Telitacicept,Non-Responder,6M
SLE-drug,S842,LDA,P35,55,female,0,belimumab,Responder,6M
SLE-naive,S016,MDA,P36,58,female,8,-,-,-
SLE-naive,S017,MDA,P37,28,Female,8,-,-,-
SLE-naive,S021,MDA,P38,56,female,6,-,-,-
SLE-naive,S050,LDA,P39,27,Female,0,-,-,-
SLE-naive,S068,HDA,P40,23,Female,27,-,-,-
SLE-naive,S071,LDA,P41,33,Female,4,-,-,-
SLE-naive,S088,HDA,P42,30,Female,20,-,-,-
SLE-naive,S096,MDA,P43,33,female,7,-,-,-
SLE-naive,S112,HDA,P44,50,Male,32,-,-,-
SLE-naive,S117,MDA,P45,25,female,6,-,-,-
SLE-naive,S123,MDA,P46,46,female,5,-,-,-
SLE-naive,S136,MDA,P47,30,male,8,-,-,-
SLE-naive,S143,LDA,P48,28,Female,4,-,-,-
SLE-naive,S186,LDA,P49,34,Female,4,-,-,-
SLE-naive,S194,HDA,P50,30,Female,12,-,-,-
SLE-naive,S200,LDA,P51,33,Female,3,-,-,-
SLE-naive,S313,HDA,P52,25,Female,10,-,-,-
SLE-naive,S446,LDA,P53,61,female,1,-,-,-
SLE-naive,S456,HDA,P54,34,female,14,-,-,-
SLE-naive,S459,MDA,P55,14,male,6,-,-,-
SLE-naive,S462,HDA,P56,29,female,13,-,-,-
SLE-naive,S465,MDA,P57,14,male,8,-,-,-
SLE-naive,S507,HDA,P58,35,female,10,-,-,-
SLE-naive,S524,HDA,P59,48,female,12,-,-,-
SLE-treatment,S451,Inactive,P60,36,female,0,-,-,-
SLE-treatment,S453,LDA,P61,39,female,2,-,-,-
SLE-treatment,S454,Inactive,P62,38,female,0,-,-,-
SLE-naive,S609,LDA,P63,38,female,4,-,-,-
SLE-naive,S441,LDA,P64,17,female,4,-,-,-
SLE-drug,S174,HDA,P65,33,female,11,Telitacicept,Non-Responder,baseline
SLE-drug,S287,HDA,P66,31,female,10,belimumab,Non-Responder,baseline
SLE-drug,S798,MDA,P67,40,female,7,belimumab,Non-Responder,baseline
SLE-drug,S251,HDA,P68,32,female,12,belimumab,Non-Responder,baseline
SLE-drug,S257,HDA,P69,31,female,12,Telitacicept,Non-Responder,baseline
SLE-drug,S227,MDA,P70,23,male,8,belimumab,Non-Responder,baseline
SLE-drug,S475,MDA,P52,25,female,8,Telitacicept,Responder,baseline
SLE-drug,S440,MDA,P71,40,female,8,belimumab,Responder,baseline
SLE-drug,S420,MDA,P72,33,female,8,Telitacicept,Responder,baseline
SLE-drug,S370,HDA,P73,38,female,14,Telitacicept,Responder,baseline
SLE-drug,S803,MDA,P74,38,female,6,belimumab,Responder,baseline
SLE-drug,S633,HDA,P75,34,female,9,belimumab,Responder,baseline
SLE-drug,S857,LDA,P75,34,female,4,belimumab,Responder,6M
SLE-drug,S603,HDA,P76,40,female,10,belimumab,Responder,baseline
SLE-drug,S775,MDA,P77,31,female,8,belimumab,Responder,baseline
SLE-drug,S529,HDA,P66,31,female,10,belimumab,Non-Responder,6M
SLE-drug,S811,MDA,P67,40,female,7,belimumab,Non-Responder,6M
SLE-drug,S716,MDA,P71,40,female,6,belimumab,Responder,6M
SLE-drug,S741,LDA,P72,33,female,4,Telitacicept,Responder,6M
SLE-drug,S831,HDA,P78,26,female,14,Telitacicept,Responder,baseline
SLE-drug,S869,HDA,P79,31,female,11,Telitacicept,Non-Responder,baseline
SLE-drug,S975,MDA,P80,36,female,8,Telitacicept,Responder,baseline
SLE-drug,S993,MDA,P81,23,female,8,belimumab,Non-Responder,baseline
SLE-CART,S436,LDA,P82,34,female,1,CART,Responder,baseline
SLE-CART,S494,MDA,P83,21,female,5,CART,Partial-Responder,baseline
SLE-CART,S461,LDA,P84,32,female,1,CART,Responder,baseline
SLE-CART,S851,LDA,P85,29,female,3,CART,Responder,baseline
SLE-CART,S858,LDA,P86,42,female,1,CART,Responder,baseline
SLE-CART,S712,LDA,P87,38,female,4,CART,Non-Responder,baseline
SLE-CART,S963,MDA,P88,36,female,5,CART,Partial-Responder,baseline
SLE-CART,S891,LDA,P84,32,female,0,CART,Responder,6M
SLE-CART,S916,LDA,P82,34,female,0,CART,Responder,6M
SLE-CART,S854,MDA,P83,21,female,5,CART,Partial-Responder,6M
SLE-CART,S846,LDA,P87,38,female,4,CART,Non-Responder,6M
HD,HD54,Healthy_control,P89,31,female,-,-,-,-
HD,HD55,Healthy_control,P90,45,female,-,-,-,-
SLE-treatment,S546,MDA,P91,51,female,8,-,-,-
SLE-treatment,S549,LDA,P92,46,female,1,-,-,-
SLE-treatment,S556,MDA,P93,26,female,6,-,-,-
SLE-treatment,S733,HDA,P94,41,female,9,-,-,-
SLE-treatment,S746,HDA,P95,36,female,12,-,-,-
SLE-treatment,S998,LDA,P88,36,female,2,CART,Partial-Responder,3M
SLE-treatment,S987,LDA,P85,29,female,1,CART,Responder,3M
SLE-treatment,S967,LDA,P86,42,female,0,CART,Responder,3M
dsRNA-RIP,HD0902,dsRNA-RIP,P111,-,-,-,0,0,0
dsRNA-RIP,HD1109,dsRNA-RIP,P112,-,-,-,0,0,0
dsRNA-RIP,HD32,Healthy_control,P96,26,female,0,0,0,0
dsRNA-RIP,HD33,Healthy_control,P97,29,female,0,0,0,0
dsRNA-RIP,S560,MDA,P98,42,female,8,0,0,0
dsRNA-RIP,S562,MDA,P99,35,female,6,0,0,0
dsRNA-RIP,S565,HDA,P100,42,female,14,0,0,0
dsRNA-RIP,S566,LDA,P101,21,female,2,0,0,0
dsRNA-RIP,S567,HDA,P102,40,female,20,0,0,0
dsRNA-RIP,S568,HDA,P103,38,female,22,0,0,0
dsRNA-RIP,S571,Healthy_control,P104,51,female,-,-,-,-
dsRNA-RIP,S579,HDA,P105,39,female,9,0,0,0
dsRNA-RIP,S583,Healthy_control,P106,53,female,-,-,-,-
dsRNA-RIP,S586,HDA,P107,44,female,12,0,0,0
dsRNA-RIP,S589,MDA,P108,61,female,7,0,0,0
dsRNA-RIP,S590,Healthy_control,P109,49,female,-,-,-,-
dsRNA-RIP,S591,Healthy_control,P110,50,female,-,-,-,-
m6A-seq,HD25,Healthy_control,P17,30,female,-,-,-,-
m6A-seq,HD27,Healthy_control,P19,37,female,-,-,-,-
m6A-seq,S507,HDA,P58,35,female,10,-,-,-
m6A-seq,S524,HDA,P59,48,female,12,-,-,-